习勉 - 中山大学 - 肿瘤防治中心

个人简介

2007.08-2010.12 中山大学肿瘤防治中心放疗科，住院医师 2010.12-2015.12 中山大学肿瘤防治中心放疗科，主治医师 2015.12-2020.12 中山大学肿瘤防治中心放疗科，副主任医师 2016-2017 美国M.D. Anderson肿瘤中心，访问学者 2020.12-至今中山大学肿瘤防治中心放疗科，主任医师 2023.12-至今中山大学肿瘤防治中心放疗科，教授

研究领域

1、食管癌的放射治疗与综合治疗；2、放射治疗新技术在肝癌的临床应用研究；3、鼻咽癌放疗后放射诱发肿瘤的临床研究。

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1. Chen B#, Liu S#, Zhu Y#, Wang R#, Cheng X, Chen B, Dragomir MP, Zhang Y, Hu Y, Liu M, Li Q*, Yang H*, Xi M*. Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab. Nat Commun. 2024;15(1):1919. 2. Zhu Y#, Wen J#, Li Q#, Chen B#, Zhao L#, Liu S, Yang Y, Wang S, Lv Y, Li J, Zhang L, Hu Y*, Liu M*, Xi M*. Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001): a single-arm, phase 2 trial. Lancet Oncol. 2023;24(4):371-382. 3. Zhou S#, Wang Y#, Zhang R#, Zeng W#, Liu S, Liu S, Liu M, Yang H*, Xi M*. Association of Sialic Acid-Binding Immunoglobulin-Like Lectin 15 With Phenotypes in Esophageal Squamous Cell Carcinoma in the Setting of Neoadjuvant Chemoradiotherapy. JAMA Netw Open. 2023;6(1):e2250965. 4. Chen R#, Liu Q#, Li Q#, Zhu Y#, Zhao L#, Liu S#, Chen B, Liu M, Hu Y, Lin T, Li J, Chen J, Lv Y, Fu J*, Xi M*, Yang H*. A phase II clinical trial of toripalimab combined with neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (NEOCRTEC1901). EClinicalMedicine. 2023;62:102118. 5. Cheng X#, Chen B#, Wang S#, Zhang J, Zhu J, Liu M, Liu S*, Xi M*. Association between lymphopenia and survival outcomes in esophageal carcinoma patients receiving combined immunotherapy and chemoradiotherapy. Oncologist. 2023;28(8):e606-e616. 6. Wang Y#, Li Q#, Zhang L, Liu S, Zhu J, Yang Y, Liu M, Zhang Y*, Xi M*. Efficacy and dose-response relationship of stereotactic body radiotherapy for abdominal lymph node metastases from hepatocellular carcinoma. Oncologist. 2023;28(6):e369-e378. 7. Wen J#, Fang S#, Hu Y#, Xi M#, Weng Z, Pan C, Luo K, Ling Y, Lai R, Xie X, Lin X, Lin T, Chen J, Liu Q*, Fu J*, Yang H*. Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma. EBioMedicine. 2022;86: 104371.